Miniatura

Fitxers

733485.pdf (11.29 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2023-05

Llicència de publicació

cc-by-nc-nd (c) Soler-Vázquez, M. Carmen et al., 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/201162

Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1016/j.ymben.2023.04.010

Resum

Obesity and its associated metabolic comorbidities are a rising global health and social issue, with novel therapeutic approaches urgently needed. Adipose tissue plays a key role in the regulation of energy balance and adipose tissue-derived mesenchymal stem cells (AT-MSCs) have gained great interest in cell therapy. Carnitine palmitoyltransferase 1A (CPT1A) is the gatekeeper enzyme for mitochondrial fatty acid oxidation. Here, we aimed to generate adipocytes expressing a constitutively active CPT1A form (CPT1AM) that can improve the obese phenotype in mice after their implantation. AT-MSCs were differentiated into mature adipocytes, subjected to lentivirus-mediated expression of CPT1AM or the GFP control, and subcutaneously implanted into mice fed a high-fat diet (HFD). CPT1AM-implanted mice showed lower body weight, hepatic steatosis and serum insulin and cholesterol levels alongside improved glucose tolerance. HFD-induced increases in adipose tissue hypertrophy, fibrosis, inflammation, endoplasmic reticulum stress and apoptosis were reduced in CPT1AM-implanted mice. In addition, the expression of mitochondrial respiratory chain complexes was enhanced in the adipose tissue of CPT1AM-implanted mice. Our results demonstrate that implantation of CPT1AM-expressing AT-MSC-derived adipocytes into HFD-fed mice improves the obese metabolic phenotype, supporting the future clinical use of this ex vivo gene therapy approach.

Matèries

Obesitat, Teixit adipós, Inflamació, Glucosa, Ratolins (Animals de laboratori)

Matèries (anglès)

Obesity, Adipose tissues, Inflammation, Glucose, Mice (Laboratory animals)

Citació

Col·leccions

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Bioquímica i Fisiologia)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

SOLER VÁZQUEZ, M. carmen, ROMERO ROMERO, María del mar, TODORČEVIĆ, Marijana, DELGADO, Katia, CALATAYUD ARISTOY, Carles, BENÍTEZ AMARO, Aleyda, LA CHICA LHOËST, Maria teresa, MERA NANÍN, Paula, ZAGMUTT CAROXA, Sebastián, BASTÍAS-PÉREZ, Marianela, IBEAS, Kevin, CASALS, Núria, ESCOLÀ GIL, Joan carles, LLORENTE CORTÉS, Vicenta, CONSIGLIO, Antonella, SERRA I CUCURULL, Dolors, HERRERO RODRÍGUEZ, Laura. Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. _Metabolic Engineering_. 2023. Vol. 77, núm. 256-272. [consulta: 23 de gener de 2026]. ISSN: 1096-7176. [Disponible a: https://hdl.handle.net/2445/201162]

Exportar metadades

JSON - METS

Compartir registre